Vikas Aurora
Overview
Explore the profile of Vikas Aurora including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
24
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Winter J, Li S, Aurora V, Variakojis D, Nelson B, Krajewska M, et al.
Clin Cancer Res
. 2010 Apr;
16(8):2435-42.
PMID: 20371683
Purpose: To prospectively investigate the prognostic significance of p21 and p53 expression in diffuse large B-cell lymphoma in the context of the U.S. Intergroup trial comparing conventional cyclophosphamide, doxorubicin, vincristine,...
2.
Isayama T, OBrien B, Ugalde I, Muller J, Frenz A, Aurora V, et al.
J Comp Neurol
. 2009 Oct;
517(4):459-80.
PMID: 19790267
The ferret is the premiere mammalian model of retinal and visual system development, but the spectrum and properties of its retinal ganglion cells are less well understood than in another...
3.
Aurora V, Winter J
Expert Opin Pharmacother
. 2006 Jun;
7(10):1273-90.
PMID: 16805715
Over the past two decades, the incidence of follicular lymphoma has increased. Contemporary treatments include combinations of chemotherapy and monoclonal antibodies, radioimmunotherapy, new targeted agents and stem-cell transplantation. Prognostic tools...
4.
Aurora V, Winter J
Blood Rev
. 2006 Jan;
20(4):179-200.
PMID: 16410034
Follicular lymphoma (FL) is characterized by its responsiveness to initial therapy, a pattern of repeated relapses, and a tendency for histologic progression to a process resembling diffuse, large B-cell lymphoma....
5.
Aiyagari A, Taylor B, Aurora V, Young S, Shannon K
Blood
. 2002 Nov;
101(6):2250-2.
PMID: 12433685
Posttranslational processing of Ras proteins has attracted considerable interest as a potential target for anticancer drug discovery. Rce1 encodes an endoprotease that facilitates membrane targeting of Ras and other prenylated...